-
The TCR-T therapy that makes up for the shortcomings of CAR-T is favored by capital and has a promising prospect
Time of Update: 2021-08-13
The company's main product under research, TK-8001, is expected to enter Phase I/II clinical trials this year to treat MAGE-A1 positive solid tumors .
TCR-T treatment process (Source: Xiangxue Pharmaceutical official website)T-knife Therapeutics’ TK-8001 is developed using the company’s humanized T cell receptor (HuTCR) mouse platform.
-
China’s first ambroxol hydrochloride spray was officially approved, Luoxin Pharmaceutical’s exclusive research and development fills the gap in the children’s drug market
Time of Update: 2021-08-13
As the first and only child-specific expectorant spray in China, the approval of ambroxol hydrochloride spray is expected to solve the problem that existing dosage forms cannot meet clinical needs, and enable high-quality innovative drugs to better serve The field of medicine for children in China .
-
Chia Tai Tianqing Bevacizumab biosimilar drug reported to be listed, domestic market competition has become fierce
Time of Update: 2021-08-13
On June 14, 2020, Betta Pharmaceuticals announced that the company and Tianguangshi are jointly developing a marketing authorization application for the bevacizumab biosimilar MIL60, which has been accepted by the State Food and Drug Administration for late, metastatic or Treatment of patients with recurrent non-small cell lung cancer and metastatic colorectal cancer .
-
Negative growth for the first time in the past 5 years!
Time of Update: 2021-08-13
The sales scale of the terminal diabetic chemical drug market in physical pharmacies in cities in China (100 million yuan)Source: Mi Nei. com, China's urban physical pharmacy terminal competition patternSales of half of the top 10 non-insulin hypoglycemic drugs declined year-on-yearSales of half of the top 10 non-insulin hypoglycemic drugs declined year-on-yearIn 2020, the market share of TOP10 non-insulin hypoglycemic drugs totaled 71.
-
Guinea finds first confirmed case of Marburg haemorrhagic fever
Time of Update: 2021-08-13
The statement said that the Ministry of Health of Guinea found a suspected case of Marburg haemorrhagic fever in the southeastern province of Gekedu on the 3rd.
-
12 pediatric Class 1 new drugs are eye-catching, Hengrui, etc. to grab the first three major direction Nuggets 70 billion market
Time of Update: 2021-08-13
A few days ago, the development of new pediatric drugs is frequent: China’s first child-specific expectorant spray has been approved for marketing, and clinical trials of the BC0335 particle for children’s respiratory syncytial virus infection have been suspended.
-
The existing 144 high-risk areas have the highest number since normalized prevention and control
Time of Update: 2021-08-13
It is necessary to strictly and quickly promote the regional investigation of newly discovered infected persons, and do a good job in the management of key personnel in key areas to prevent the spread of the epidemic .
-
The new coronavirus has spread to wild animals
Time of Update: 2021-08-13
The researchers said that this phenomenon is worrying, but more research is needed to assess whether the new crown virus will spread in the wild population of deer, or spread between species .
-
Zhang Wenhong: There is no vaccine for 100% infection prevention
Time of Update: 2021-08-13
The epidemic prevention and control must be wide, fast and early China News Service, August 3 (Reporter Chen Jing) Wu Jinglei, director of the Shanghai Municipal Health Commission, said on the 3rd that as of August 2, the number of people in Shanghai who had completed the entire vaccination had reached 18.
-
"Politicizing scientific issues will not bring any benefit"
Time of Update: 2021-08-13
Democratic chairman China's openness and transparency, timely and effective control of the epidemicChina's openness and transparency, timely and effective control of the epidemic South Africa’s Deputy Director-General of the Ministry of Foreign Affairs Sukraal said that China’s cooperation in the World Health Organization virus traceability issue is commendable .
-
The paper shows: U.S. wild animals have new crown antibodies in 2019
Time of Update: 2021-08-13
Scholars from the National Center for Wildlife Research in the United States tracked neutralizing antibodies and pushed the time when the new coronavirus appeared in wild animals in the United States to 2019!
-
Be alert to the outbreak of nucleic acid testing sites!
Time of Update: 2021-08-13
Samples were taken at the same site before the diagnosis of multiple cases In the recent local epidemic, Nanjing, Yangzhou, Zhangjiajie, Yantai, Zhengzhou and other places have carried out multiple rounds of large-scale nucleic acid testing .
-
Global ADC transaction inventory
Time of Update: 2021-08-13
This article summarizes the global ADC blockbuster transactions from 2019 to the present as follows:Coincidentally, yesterday, Daiichi Sankyo and AstraZeneca announced the jointly developed second-line HER2-targeting antibody conjugate DS-8201 for the second-line treatment of HER2-positive unresectable and/or metastatic breast cancer Phase 3 H2H trial DESTINY-Breast03 (NCT03529110 ) Top line data .
-
Jiahe Bio-CDK4/6 inhibitor starts phase 3 clinical trial
Time of Update: 2021-08-13
On August 6, the Insight database showed that Jiahe Biologics CDK4/6 inhibitors started phase III clinical trials, combined with fulvestrant to treat hormone receptor (HR) positive human epidermal growth factor receptors after previous endocrine therapy.
-
Why does the concept of the close linker change?
Time of Update: 2021-08-13
What the experts say Our reporter Ye Qing Why is the past concept of close contact for patients with new coronary pneumonia no longer applicable?
What is the impact of the change in the concept of close contact on the epidemic prevention and control measures?
-
Tongce Medical's net profit of 351 million yuan in 2021H1 surged by 141% year-on-year, and the number of outpatients in the province increased
Time of Update: 2021-08-13
At the same time, with the optimization and improvement of the company's management level, the expense ratio during the period will remain at the current level or slightly decrease, and the company's net profit is expected to grow further in the second half of the year, which will increase on a large scale compared with the same period last year .
-
National Health Commission: my country's existing epidemic prevention and control measures are effective for Delta
Time of Update: 2021-08-13
National Health Commission: my country’s current epidemic prevention and control measures are still effective for Delta.
The delta variant is currently the main strain in the global epidemic of new crown pneumonia .
-
Safe treatment of children's myopia Santen Pharmaceutical reached atropine preparation license agreement
Time of Update: 2021-08-13
On August 10, 2021, Santen and Sydnexis announced that they have reached an exclusive license agreement for the development and promotion of Sydnexis's low-dose atropine preparation SYD-101 in Europe, the Middle East and Africa (EMEA) .
-
WHO calls for suspension of COVID-19 booster injections before the end of September
Time of Update: 2021-08-13
Tan Desai said that we need to move most vaccines from high-income countries to low-income countries .
Tan Desai emphasized that vaccination is not a single way to control the epidemic, it needs to be combined with effective public health protection measures .
-
Experts interpret issues related to new crown vaccine injection and prompt protection
Time of Update: 2021-08-13
Studies have shown that vaccination is still the most effective way to prevent the new coronavirus, and people who have completed the new crown vaccination still need to take personal daily protection .
